[HTML][HTML] Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway
Y Liu, H Zhuang, F Cao, J Li, Y Guo, J Zhang… - Cell Death & …, 2021 - nature.com
Hepatocellular carcinoma (HCC) is one of the most common cancers with an insidious
onset, strong invasiveness, insensitivity to chemotherapy, and poor prognosis, thus makes …
onset, strong invasiveness, insensitivity to chemotherapy, and poor prognosis, thus makes …
Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway.
Y Liu, H Zhuang, F Cao, J Li, Y Guo… - Cell Death & …, 2021 - search.ebscohost.com
Hepatocellular carcinoma (HCC) is one of the most common cancers with an insidious
onset, strong invasiveness, insensitivity to chemotherapy, and poor prognosis, thus makes …
onset, strong invasiveness, insensitivity to chemotherapy, and poor prognosis, thus makes …
Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway.
Y Liu, H Zhuang, F Cao, J Li, Y Guo, J Zhang… - Cell Death & …, 2021 - europepmc.org
Hepatocellular carcinoma (HCC) is one of the most common cancers with an insidious
onset, strong invasiveness, insensitivity to chemotherapy, and poor prognosis, thus makes …
onset, strong invasiveness, insensitivity to chemotherapy, and poor prognosis, thus makes …
Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway
Y Liu, H Zhuang, F Cao, J Li, Y Guo… - Cell death & …, 2021 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most common cancers with an insidious
onset, strong invasiveness, insensitivity to chemotherapy, and poor prognosis, thus makes …
onset, strong invasiveness, insensitivity to chemotherapy, and poor prognosis, thus makes …
[HTML][HTML] Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway
Y Liu, H Zhuang, F Cao, J Li, Y Guo, J Zhang… - Cell Death & …, 2021 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most common cancers with an insidious
onset, strong invasiveness, insensitivity to chemotherapy, and poor prognosis, thus makes …
onset, strong invasiveness, insensitivity to chemotherapy, and poor prognosis, thus makes …
Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway
Y Liu, Z Hao, F Cao, J Li, Y Guo, J Zhang… - Cell Death and …, 2021 - search.proquest.com
Hepatocellular carcinoma (HCC) is one of the most common cancers with an insidious
onset, strong invasiveness, insensitivity to chemotherapy, and poor prognosis, thus makes …
onset, strong invasiveness, insensitivity to chemotherapy, and poor prognosis, thus makes …